17 December 2020 in Acta Biochimica Polonica
Background: MicroRNAs play a crucial role in diabetic peripheral neuropathic pain (DPNP). miR-590-3p is a novel miRNA and involved in multiple diseases. However, the pathological mechanism of miR-590-3p in DPNP needs to be elucidated. Materials and methods: The db/db mice and db/m mice were selected to mimic diabetes and control, respectively, for in vivo studies. The miR-590-3p agomir was injected into db/db mice and pain-related behavioral tests were performed. The interaction of miR-590-3p with target gene was confirmed by dual-luciferase reporter assay. The expression of target gene was determined by qRT-PCR and western blot assay. The levels of inflammatory cytokines were measured by enzyme-linked immunosorbent assay (ELISA). Results: miR-590-3p was down-regulated in diabetic peripheral neuropathy mice. More importantly, miR-590-3p agomir alleviated pain-related behavior, reduced TNF-α, IL-1β and IL-6 concentrations, and inhibited neural infiltration by immune cells in db/db mice. Interestingly, RAP1A was predicted to be the target of miR-590-3p by Targetscan, and was actually regulated by miR-590-3p. Finally, the rescue experiments proved that overexpression of RAP1A partially abrogated the suppressive impact of miR-590-3p on T cells proliferation and migration. Conclusion: miR-590-3p ameliorates DPNP via targeting RAP1A and inhibiting T cells infiltration, indicating that exogenous miR-590-3p may be a potential candidate for clinical treatment of DPNP.
20 August 2021 in Advances in Clinical and Experimental Medicine
Cerebrovascular disease is currently a serious threat to human health and life, commonly including cerebral infarction, cerebral hemorrhage and transient cerebral ischemia, among others. To explore the role and e molecular mechanism of GP6 in the development of cerebral ischemic stroke (CIS) induced by atherosclerosis (AS). Forty-five male New Zealand white rabbits were randomly divided into 3 groups: the control, CIS model and anti-GP6 group. Carotid artery tissues and blood of the white rabbits were collected for analysis. Hematoxylin and eosin (H&E) staining was used to analyze the pathological characteristics of vascular endothelial injury. Flow cytometry (FCM) was performed to analyze the content of Th1 and Th17 in blood. Immunohistochemistry was used to analyze the distribution and relative expression of FCER1G, ITGA2 and GP6 proteins in the carotid artery and cerebrovascular tissues. Western blot was applied to determine the protein expression of GP6, FYN, PKA, pPTK2, and pFAK1 in carotid artery tissues of the rabbits. In the CIS model group, there was lymphocyte infiltration, fibrous tissue formation, and the formation of thrombus and lipid plaques. In the anti-GP6 group, scattered thin plaques were observed, and no obvious foam cell deposition was observed. The Th1 and Th17 content was significantly decreased in the CIS model group compared to the control and anti-GP6 group. The relative expression of FCER1G, ITGA2 and GP6 in the CIS model group was significantly higher compared to those in the control group and anti-GP6 group. The protein expression of GP6, FYN, PKA, pPTK2, and pFAK1 in the CIS model group were markedly higher compared to those in the control group and anti-GP6 group. GP6 can promote the development of CIS by activating the FYN-PKA-pPTK2/FAK1 signaling pathway.